A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Autor: Smorenburg, C.H. *, de Groot, S.M., van Leeuwen-Stok, A.E., Hamaker, M.E., Wymenga, A.N., de Graaf, H., de Jongh, F.E., Braun, J.J., Los, M., Maartense, E., van Tinteren, H., Nortier, J.W.R., Seynaeve, C.
Zdroj: In Annals of Oncology March 2014 25(3):599-605
Databáze: ScienceDirect